ArriVent BioPharma, Inc. (NASDAQ: AVBP) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ARRIVENT BIOPHARMA, INC.

ArriVent BioPharma, Inc. (NASDAQ: AVBP)
Listen to this Section


$30.74
-2.3600 ( -7.13% ) 311.5K

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Market Data


Open $30.74
Previous Close $33.09
Volume 311.5K
Market Cap $1.54B
Day Range $30.55 - $33.33
52 Week Range $16.10 - $33.62
Shares Outstanding 46.57M
Change % -7.13%
Net Change ▼ -2.3600
Insider Ownership 0.00%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2024
CountryUnited States
UnderwriterGoldman Sachs, Jefferies, Citi, LifeSci Capital, more

Insider Ownership Transactions

Total Amount Purchased: -58,137.00

Date Type Amount Purchased Purchaser
2024-05-20 Sale -29550.00 Hohneker John
2024-04-23 Sale -28587.00 Peterson Kristine

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025
8-k 8K-related 12 Jun 20, 2025

Latest News


× Before browsing our site, please accept our cookies policy